← Home
📢 Press Releases
| Date | Press release |
|---|---|
| 2026-03-20 16:17:00 | Imaginostics Receives Siemens Healthineers Letter Of Support As Companies Advance Quantitative Mri Dialogue Orlando, fla.--(business wire)-- #alzheimers--imaginostics, inc. today announced that it has received a letter of support from siemens healthineers in connection with ongoing exploratory discussions regarding potential collaboration in quantitative mri and imaging biomarkers. as part of these discussions, imaginostics and siemens healthineers intend to continue dialogue concerning potential technical and commercial pathways for imaginostics’ envisioned imagiview™ and imagisight™ offerings and their potential. |
| 2026-03-18 08:30:00 | Siemens Healthineers Launches Brain Health Research Portfolio With First Biomarker Assays Now Available Brain-derived, fully automated atellica im phosphorylated tau 217 (ptau217) and atellica im brain derived tau (bdtau) assays now available for research use brain-derived, fully automated atellica im phosphorylated tau 217 (ptau217) and atellica im brain derived tau (bdtau) assays now available for research use |
| 2026-03-09 05:53:00 | Ki Reply And Data Reply Lay The Strategic Foundation For Ai Innovation At Siemens Healthineers With “cerebra” Turin, italy--(business wire)--ki reply and data reply, the reply group companies specialised respectively in ai-powered software development and data-driven solutions, have partnered with the “crm excellence” department of medical technology company siemens healthineers to develop “cerebra“, an advanced ai platform designed to deliver rapid, relevant insights across marketing and sales. the concept proved so successful that “cerebra” was evolved into an agent factory, which now standardises, s. |
| 2025-09-30 08:30:00 | New Drug Testing Analyzer From Siemens Healthineers Raises The Bar For Court, Military, And Forensics Testing, Offering Clinical-quality Results Tarrytown, n.y.--(business wire)-- #drugtesting--new drug testing analyzer helps identify substance use, monitor therapeutic and immunosuppressant drugs, and perform serum toxicology testing. |
| 2025-09-23 07:00:00 | Vedabio Announces Strategic Agreement With Siemens Healthineers And Series A Extension, Totaling Up To $25 Million San diego--(business wire)--vedabio, a pioneering biotechnology company transforming molecular detection, today announced a series a extension alongside a strategic agreement with siemens healthineers. together, these commitments total up to $25 million for advancing vedabio’s crispr-based product platform. moreover, it is an important step in validating vedabio’s vision of leveraging an amplification-free technology to meet critical unmet needs in decentralized molecular diagnostics. “the comb. |
| 2025-09-03 15:42:00 |
|
| 2025-07-24 08:30:00 |
|
| 2025-05-05 09:36:00 |
|
| 2025-05-01 02:00:00 |
|
| 2025-02-28 06:37:00 |
|
| 2025-02-04 08:45:00 |
|
| 2025-01-08 13:00:00 |
|
| 2024-12-02 07:30:00 |
|
| 2024-09-26 08:01:00 |
|
| 2024-07-19 10:16:00 |
|
📰 Browse additional press releases for Siemens Healthineers!
Sign up for free or log in🙌 Join now to get "The Checklist Value Investor — A Smarter Way to Pick Stocks" at no cost